ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ALLR Company Profile and Key Details

NASDAQ : ALLR

Allarity Therapeutics, Inc.

$0.83

-0.0538-6.09%

Open: 1:15 PM

64.83

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ALLR Stock Price Chart

Stock Price Today

Allarity Therapeutics, Inc. (ALLR) stock declined over -6.09%, trading at $0.83 on NASDAQ, down from the previous close of $0.88. The stock opened at $0.81, fluctuating between $0.76 and $0.86 in the recent session.

Stock Snapshot

0.8836

Prev. Close

0.81

Open

3.68M

Market Cap

4.43M

Number of Shares

0.7601

Day Low

0.8594

Day High

N/A

P/E Ratio

76.43%

Free Float in %

5449.42

EPS (TTM)

-1.38

Book Value

-6.4

Cash Flow per Share

799.18K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2025	0.88	0.91	0.86	0.88	1.28M
Apr 01, 2025	0.96	1.00	0.86	0.91	904.16K
Mar 31, 2025	1.02	1.03	0.93	0.94	1.26M
Mar 28, 2025	1.02	1.08	0.99	1.04	1M
Mar 27, 2025	1.10	1.20	0.91	1.05	3.28M
Mar 26, 2025	1.14	1.23	1.09	1.14	3.89M
Mar 25, 2025	1.01	1.12	0.95	1.11	3.05M
Mar 24, 2025	1.05	1.09	0.99	1.00	3.61M
Mar 21, 2025	0.94	1.05	0.90	0.99	2.47M
Mar 20, 2025	0.99	1.01	0.92	0.96	1.15M
Mar 19, 2025	0.85	1.09	0.83	1.00	4.41M
Mar 18, 2025	0.91	0.95	0.82	0.85	1.48M
Mar 17, 2025	0.98	1.03	0.90	0.93	1.02M
Mar 14, 2025	0.91	0.98	0.87	0.96	935.53K
Mar 13, 2025	1.03	1.04	0.85	0.90	2.39M
Mar 12, 2025	1.07	1.12	1.01	1.02	1.63M
Mar 11, 2025	1.13	1.14	1.00	1.08	2.41M
Mar 10, 2025	1.09	1.24	1.07	1.12	5.14M
Mar 07, 2025	1.00	1.10	0.98	1.06	2.56M
Mar 06, 2025	1.05	1.09	0.96	1.04	4.45M

Contact Details

Cambridge, MA 02139

United States

Website: https://www.allarity.comContact: 401 426 4664

About Company

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microtubule inhibitor for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. The company was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Allarity Therapeutics, Inc. (ALLR) stock price?

Allarity Therapeutics, Inc. (NASDAQ: ALLR) stock price is $0.83 in the last trading session. During the trading session, ALLR stock reached the peak price of $0.86 while $0.76 was the lowest point it dropped to. The percentage change in ALLR stock occurred in the recent session was -6.09% while the dollar amount for the price change in ALLR stock was -$0.05.

ALLR's industry and sector of operation?

The NASDAQ listed ALLR is part of Biotechnology industry that operates in the broader Healthcare sector. Allarity Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALLR?

Mr. James G. Cullem J.D.
Chief Executive Officer, Chief Bus. Officer, SVice President of Corporation Devel., Sec. & Director
Ms. Joan Brown
Chief Financial Officer & Director of Financial Reporting
Ms. Joan Y. Brown
Interim Chief Financial Officer & Director of Financial Reporting
Dr. Steen Meier Knudsen Ph.D.
Founder & Chief Scientific Officer
Mr. Thomas H. Jensen
Founder, Senior Vice President of Investor Relations & Director
Dr. Marie Foegh DrSc, M.D.
Chief Medical Officer
Mr. Peter Buhl Jensen Adj Professor, M.D., M.D., Ph.D., Ph.D.
Co-Founder
Mr. Claus Frisenberg Pedersen
Chief Commercial Officer
Ms. Annie Rasmussen
Chief of Clinical Operations

How ALLR did perform over past 52-week?

ALLR's closing price is 30.32% higher than its 52-week low of $0.68 where as its distance from 52-week high of $174.00 is -99.49%.

How many employees does ALLR have?

Number of ALLR employees currently stands at 5.

Link for ALLR official website?

Official Website of ALLR is: https://www.allarity.com

How do I contact ALLR?

ALLR could be contacted at phone 401 426 4664 and can also be accessed through its website. ALLR operates from 210 Broadway, Cambridge, MA 02139, United States.

How many shares of ALLR are traded daily?

ALLR stock volume for the day was 799.18K shares. The average number of ALLR shares traded daily for last 3 months was 2.8M.

What is the market cap of ALLR currently?

The market value of ALLR currently stands at $3.68M with its latest stock price at $0.83 and 4.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	5
Beta	0.25
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology